FDA recall, , Moderate risk
LifeShare Blood Center Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced had a platelet count higher than acceptable.
Recall ended Sep 14, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeShare Blood Center recalled Apheresis Platelets, Leukocytes Reduced because a platelet count higher than was acceptable was distributed. The recall began October 8, 2025, and was classified by the FDA on September 14, 2026. The product was distributed in Louisiana.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeShare Blood Center
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99554
- Recall number
- B-0238-2026
All recalls from LifeShare Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
